GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (FRA:RWMA) » Definitions » 3-Year Revenue Growth Rate

Rockwell Medical (FRA:RWMA) 3-Year Revenue Growth Rate : -26.50% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Rockwell Medical 3-Year Revenue Growth Rate?

Rockwell Medical's Revenue per Share for the three months ended in Mar. 2024 was €0.71.

During the past 12 months, Rockwell Medical's average Revenue per Share Growth Rate was -28.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was -26.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -22.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was -12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Rockwell Medical was 32.00% per year. The lowest was -26.50% per year. And the median was -1.70% per year.


Competitive Comparison of Rockwell Medical's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's 3-Year Revenue Growth Rate falls into.



Rockwell Medical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Rockwell Medical  (FRA:RWMA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Rockwell Medical 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical (FRA:RWMA) Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

Rockwell Medical (FRA:RWMA) Headlines

No Headlines